Total investments 38
Average round size 
$150M
The average size of a deal this fund participated in
Portfolio companies 33
Lead investments 1
Follow on index
0.13How often the fund supports its portfolio startups at next rounds
Exits 7
Key employees Soon
New York, New York, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Octagon Capital Advisors:
Typical Co-investors
Octagon Capital Advisors is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Octagon Capital Advisors:
There are no funds here. If we find new data, we will add it here.
Funds with similar focus
Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| babemax | China, Putuo, Shanghai |
| Beiqing Ruichuang | Beijing, Beijing Shi, China |
| Cooley | California, Palo Alto, United States |
| Cyberlink Corp | California, San Jose, United States |
| Danfu Investment | - |
| Esplanade Ventures | Canada, Montréal, Quebec |
| Essence VC | - |
| GP Ventures | Illinois, Illinois City, United States |
| Huayu Kechuang | Beijing, China, Haidian |
| Hunan Zhongai Social Impact Investment | China, Fujian, Hunan |
| Kodansha | Chiyoda, Japan |
| Millenium Food-Tech | - |
| MPM Bio IV NVS Strategic Fund | - |
| Old Lane LP | New York, New York, United States |
| PKO BP | Mazowieckie, Poland, Warszawa |
| QUBIS | Belfast, Northern Ireland, United Kingdom |
| Ricoh Company | Japan, Tokyo |
| Salamander Invest AS | - |
| Zhiyou Fangcun | China, Guangdong, Shenzhen |
| Zhongjiancai Touzi | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bluejay Therapeutics | $182M | 09 May 2024 | - | ||
ProfoundBio | $112M | 13 Feb 2024 | Suzhou, Jiangsu, China | ||
Alebund Pharmaceuticals | $30M | 12 Apr 2023 | Shanghai, China | ||
ArriVent Biopharma | $155M | 29 Dec 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
Bluejay Therapeutics | $41M | 16 Aug 2022 | - | ||
ArriVent Biopharma | $69M | 15 Feb 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
AnHeart Therapeutics | $61M | 14 Dec 2021 | Shangcheng District, Zhejiang, China | ||
Allorion Therapeutics | $40M | 24 Nov 2021 | Natick, Massachusetts, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Octagon Capital Advisors?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 38
Average round size 150M
Peak activity year 2021
Lead investments 1
Follow on index 0.13
Exits 7
Group Appearance index 0.97
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bluejay Therapeutics | $182M | 09 May 2024 | - | ||
ProfoundBio | $112M | 13 Feb 2024 | Suzhou, Jiangsu, China | ||
Alebund Pharmaceuticals | $30M | 12 Apr 2023 | Shanghai, China | ||
ArriVent Biopharma | $155M | 29 Dec 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
Bluejay Therapeutics | $41M | 16 Aug 2022 | - | ||
ArriVent Biopharma | $69M | 15 Feb 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
AnHeart Therapeutics | $61M | 14 Dec 2021 | Shangcheng District, Zhejiang, China | ||
Allorion Therapeutics | $40M | 24 Nov 2021 | Natick, Massachusetts, United States |
